Case Studies
MVMD's patented Soluvec™ pharmacokinetic characterization study published
Read the physical and pharmacokinetic characterization of MVMD's Soluvec™, a novel, solvent-free aqueous ivermectin formulation
MVMD & Agrarius: The Partnership That’s Revolutionizing Agriculture
Read about Agrarius™, the worlds first all-organic plant signaling technology
.jpg)
Authority Magazine Interview with MVMD CEO
Read MVMD President & CEO, Dennis Hancock's, interview with Authority Magazine
Watch: 2022 MVMD Annual General Meeting
Watch MVMD's 2022 Annual General Meeting recap video, reviewing all of MVMD's business lanes in depth
Watch: MVMD CEO Comments on Agrarius Technology
MVMD President & CEO, Dennis Hancock, comments on Agrarius technology and discusses current progress
MVMD kicks off commercial sales of Agrarius
MVMD starts commercial sales of Agrarius™, the newest innovation of organic plant signaling technology
MVMD Completes Pre-clinical Pharmacokinetic Study for Soluvec™
Read the results for MVMD's Soluvec™ pre-clinical pharmacokinetic study.
MVMD Announces Transition of Chief Medical Officer To Advisory Role
Announcement related to Transition of Chief Medical Officer To Advisory Role
MVMD Provides Notice of Redemption For Class “B” Non-Voting Shares.
Information about Mountain Valley MD Provides Notice...
MVMD Provides Business Update, Focus on Commercialization Phase
Information about Mountain Valley MD Provides Business...
MVMD Commences Commercial Sales of Agrarius
Information about Mountain Valley MD Commences Commercial...
MVMD Successfully Completes Preclinical Pharmacokinetic Study For Soluvec™ 1%
Information about Mountain Valley MD Successfully Completes...
MVMD Holdings Provides Business Update
Information about Mountain Valley MD Holdings Provides...
MVMDAppoints Dr. Elizabeth Norton To Advisory Role
Information about Mountain Valley MD Holdings Appoints...
MVMD Announces Restricted Share Unit Plan, RSU Grant & Stock Option Grant
Announcement related to Restricted Share Unit Plan, RSU Grant and Stock Option Grant
MVMD Completes Licensing Agreement with Red White And Bloom Brands Inc.
Information about Mountain Valley MD Holdings Completes...
MVMD Announces Letter of Intent With Red White and Bloom Brands Inc.
Announcement related to Letter of Intent With Red White and Bloom Brands Inc.
MVMD Holdings Provides Business Update, Results of Shareholder Meeting
Information about Mountain Valley MD Holdings Provides...
MVMD Announces Voluntary Retraction of A Reported Data Set
Announcement related to Voluntary Retraction of A Reported Data Set, No Material Change To Business Plan Anticipated
MVMD Announces Annual Shareholder Meeting
Announcement related to Annual Shareholder Meeting
MVMD To Graduate To OTCQX Best Market & Broader Up-Listing Strategy
Information about Mountain Valley MD Holdings To...
MVMD Appoints Chief Medical Officer
Information about Mountain Valley MD Appoints Chief...
MVMD Announces Appointment of Advisors, Stock Option Grant, and Provides Update
Announcement related to Appointment of Advisors, Stock Option Grant, and Provides Uplisting Update
MVMD Announces Results From Cold Chain Storage Evaluation Of Quicksome™ Tech
Announcement related to Results From Cold Chain Storage Evaluation Of Novel Quicksome™ Technology
MVMD Provides Update on Key Strategic Initiatives
Information about Mountain Valley MD Provides Update...
MVMD Hosts Live Q&A Session With Company President & CEO
Information about Mountain Valley MD To Host...
MVMD Receives Successful Results From BSL-4 Covid-19 Trial
Information about Mountain Valley MD Receives Successful...
Mountain Valley MD Provides Update on Current Trials
Information about Mountain Valley MD Provides Update...
MVMD Proceeding with Pre-Clinical Cancer Trials, Files Related Cancer Patent
Information about Mountain Valley MD Proceeding with...
MVMD Proceeding With Application To List on TSX Venture Exchange
Information about Mountain Valley MD Holdings Inc....
MVMD Commencing Trials in Bangladesh, Striking Pharmaceutical Production Agreements
Information about Mountain Valley MD Commencing Trials...
-singh-2989628.jpeg)
MVMD Achieves Solubilization of Selamectin, Files Trademark For Selactosol™
Achievement related to Solubilization of Selamectin, Files Trademark For Selactosol™
.jpeg)
MVMD Proceeding with FDA 505(B)(2) Pathway Application for Ivectosol™
Information about Mountain Valley MD Proceeding With...
MVMD Commencing Husbandry Animal Trials, Appoints New Advisor
Information about Mountain Valley MD Commencing Husbandry...
MVMD Confirms Quicksome™ License Agreement, First Revenues
Information about Mountain Valley MD Confirms Quicksome™...
MVMD Including Testing of S. African Mutation in BSL-4 Clearance Work
Information about Mountain Valley MD To Include...
MVMD Announces Stock Option Grant & Warrant Exercise Update
Announcement related to Stock Option Grant and Warrant Exercise Update
MVMD Holdings To Commence Trading on OTCQB Market Under Ticker MVMDF
Information about Mountain Valley MD Holdings To...
MVMD Contracts Tulane University For Adjuvant IPV Study
Information about Mountain Valley MD Contracts Tulane...
MVMD Proceeding with Covid-19 Clearance Trial In BSL-4 Facility
Information about Mountain Valley MD Proceeding with...
MVMD Files Patent For Novel Vaccine Dose Sparing Adjuvant
Information about Mountain Valley MD Files Patent...
MVMD Awarded Canadian Patent For Its Quicksome™ Technology
Information about Mountain Valley MD Awarded Canadian...
MVMD Announces Application for OTCQB Listing In U.S.
Announcement related to Application for OTCQB Listing In U.S., Provides Update on Warrant Exercises
MVMD Completes Strategic Sale of Subsidiary, Finalizing Quicksome™ License Agreement
Information about Mountain Valley MD Completes Strategic...
MVMD Files For Acceleration of Patent Examination For Solubilized Ivermectin
Information about Mountain Valley MD Files For...
MVMD Holdings Oversubscribes Strategic Private Placement Offering of Units
Information about Mountain Valley MD Holdings Oversubscribes...
MVMD Announces Private Placement of Units, Appointment of Advisor, and Proposed Debt Settlement
Announcement related to Strategic Private Placement Offering of Units, Appointment of Advisor Board Members, and Proposed Debt Settlement
MVMD Confirms 800% Increase in Ivermectin Absorption with Solubilization Technology
Information about Mountain Valley MD Confirms 800%...
MVMD Secures Quicksome™ License Agreement & Strategic Sale of Subsidiary
Information about Mountain Valley MD Secures Quicksome™...
MVMD Files Patent to Protect Science Achievement in Solubilization of Ivermectin
Information about Mountain Valley MD Files Patent...
MVMD Provides Successful Quicksome™ Sublingual Pre-Clinical Trial Dosing Update
Information about Mountain Valley MD Provides Successful...
Leading Vaccine Expert Joins MVMD Advisory Board To Advance Quicksome™ Commercialization
Information about Leading Vaccine Expert Joins MVMD...
MVMD Secures Distribution Rights For Agro Stimulant
Information about Mountain Valley MD Secures Distribution...
MVMD Announces Successful Complexation of Ivermectin In Quicksome™
Announcement related to Successful Complexation of Ivermectin Drug In Quicksome™ Oral Strip and Commencement of Pre-Clinical Trials
FDA Lab Confirms Quicksome™ Successfully Preserves Polio D Antigen
Information about U.S. Food And Drug Administration...
MVMD Completes Acquisition of Colombian Cannabis Licence Suite
Information about Mountain Valley MD Holdings’ Subsidiary...
MVMD Completes Intellectual Property Asset Transfer of Quicksome™
Information about Mountain Valley MD Holdings Inc....
MVMD Announces New CFO and New Board Member
Announcement related to New CFO, New Board Member, and Transition of Previous CFO To Advisory Role
MVMD Provides Update on Property Assets, Completes Shares For Debt Transaction, and Grant of Options
Information about Mountain Valley MD Holdings Inc....
MVMD Commences Trading On CSE Under Ticker MVMD.CN
Information about Mountain Valley MD Holdings Inc....
MVMD Completes Reverse Takeover Transaction
Information about Mountain Valley MD Holdings Inc....
2023 AGM Business Presentation Video
Watch MVMD's 2023 AGM hosted on September 28th, 2023
MVMD executes license agreement, related studies, and patent expansion for Soluvec™
MVMD executes license agreement, related studies, and patent expansion for Soluvec™
MVMD Welcomes Dr. Elizabeth Norton to Advisory Role / Cold Chain and Vaccine Progress
MVMD Welcomes Dr. Elizabeth Norton to Advisory Role / Cold Chain and Vaccine Progress
Register for MVMD's 2022 AGM – Wednesday, September 29th
Register for MVMD AGM – Wednesday, September 29th
MVMD Welcomes Two New Advisors to the Team
The addition of Gokul Kannan and Mark Gelnaw to the MVMD team is expected to bring significant value as we continue to advance our key oncology and technology initiatives.
MVMD Update: FDA, Oncology, Cold Chain, Husbandry and more
MVMD Update: FDA, Oncology, Cold Chain, Husbandry and more
MVMD Selactosol™ Interview
Mike Farber and Steve Darling from Proactive Investor discussed MVMD's new water-solubilized selamectin breakthrough
New MVMD Dose Sparing Patent Filed
MVMD Files for a new, novel dose sparing patent for IPV Polio
AGRARIUS BR Corn Trial Grows Longer and Healthier Cobs of Corn
The trial showcased that corn crops treated with AGRARIUS BR retained a 23% yield increase compared to the control group.
.jpg)
California Ranch Trials Agrarius™ for Cattle
A grass-finished cattle company located in Placer County, California, tested Agrarius™ on fescue grass to evaluate its impact on cattle grazing land yields.
Field Trial of AGRARIUS BR for Cabbage in Ontario, Canada
The AGRARIUS BR treatment led to a 20% increase in the overall yield of Napa cabbage, attributed to improved plant health and faster crop growth.
Sugar Cane Farm Achieves 20% Increase in Yield with AGRARIUS BR
A sugarcane farm in Santa Cruz, Jamaica experienced a 20% yield increase when using AGRARIUS BR on their crops.
Increased Potato Yields with Agrarius™ Technology
The use of AGRARIUS BR technology led to a significant boost in potato yields. The number of potatoes per plant increased from 14 to 30, and the overall weight of the yield increasing from 2.08kg to 3.78kg.
Subscribe to Updates
Stay plugged in on everything MVMD
Should you ever want to update your preferences or unsubscribe entirely, you can do so by contacting privacy@mvmd.com
